The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 11, 2022

Filed:

Sep. 29, 2017
Applicant:

Baylor College of Medicine, Houston, TX (US);

Inventors:

Robert Layne Kruse, Houston, TX (US);

Karl-Dimiter Bissig, Houston, TX (US);

Stephen M. G. Gottschalk, Houston, TX (US);

Thomas C. T. Shum, Houston, TX (US);

Assignee:

Baylor College of Medicine, Houston, TX (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/17 (2015.01); A61P 1/16 (2006.01); A61P 31/20 (2006.01); C07K 14/725 (2006.01); C07K 14/705 (2006.01); C07K 16/08 (2006.01); C12N 15/11 (2006.01);
U.S. Cl.
CPC ...
A61K 35/17 (2013.01); A61P 1/16 (2018.01); A61P 31/20 (2018.01); C07K 14/7051 (2013.01); C07K 14/70521 (2013.01); C07K 16/082 (2013.01); C12N 15/11 (2013.01); C07K 2317/21 (2013.01); C07K 2317/53 (2013.01); C07K 2317/622 (2013.01); C07K 2319/03 (2013.01); C07K 2319/33 (2013.01);
Abstract

Embodiments of the disclosure encompass immunotherapy for Hepatitis B viral (HBV) infection in an individual in need thereof. The immunotherapy comprises one or more chimeric antigen receptors (CAR) that target a HBV antigen, including CAR molecules that utilize specific scFv antibodies. In certain cases, the CAR comprises one or more mutations to reduce binding to Fc receptors. In specific aspects, cells that express the CAR(s) have reduced cytotoxicity that is safer and/or beneficial to individuals that are immunocompromised.


Find Patent Forward Citations

Loading…